Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Atazanavir (sold under the brand name Reyataz, among others) is an antiretroviral medication belonging to the protease inhibitor class, used alongside other medications to manage and treat HIV/AIDS. It works by selectively binding to the active site of the HIV protease enzyme, preventing it from cleaving vital viral polyproteins into their mature, infectious forms. This process significantly reduces the overall viral load and slows the progression of the virus
Atazanavir (sold under the brand name Reyataz, among others) is an antiretroviral medication belonging to the protease inhibitor class, used alongside other medications to manage and treat HIV/AIDS. It works by selectively binding to the active site of the HIV protease enzyme, preventing it from cleaving vital viral polyproteins into their mature, infectious forms. This process significantly reduces the overall viral load and slows the progression of the virus